companiesandmarkets.com

Return to Report | Print

Cardium Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/cardium-therapeutics,-inc.-medical-equipment-deals-and-alliances-profile-164912.asp

Report Summary

Cardium Therapeutics, Inc. (Cardium) is medical technology company that develops and commercializes biologic therapeutics and medical devices for cardiovascular and ischemic disease. Cardium assembled its portfolio of cardiovascular and regenerative medicine with the acquisition of three companies since October 2005. Its lead product candidate, Generx is a DNA based growth factor therapeutic for use by interventional cardiologists to stimulate the growth of collateral circulation in heart of patients with ischemic conditions. The company markets its products through our direct sales force. The company has two subsidiaries namely, Innercool Therapies, Inc. and Tissue Repair Company.

The Cardium Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Table of Contents


Table Of Contents
Table Of Contents 2
List of Tables 2
List of Figures 3
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2009 4
Cardium Therapeutics, Inc., Medical Equipment Deals By Type, 2004 to YTD 2009 5
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2009 6
Cardium Therapeutics, Inc., Medical Equipment, Deals By Market, 2004 to YTD 2009 7
Cardium Therapeutics, Inc., Medical Equipment, Deals Summary, 2004 to YTD 2009 8
Cardium Therapeutics, Inc., Medical Equipment, Deal Details 9
Acquisition 9
Cardium Therapeutics Acquires Tissue Repair Company 9
Cardium Therapeutics Acquires INNERCOOL therapies 10
Aries Ventures Acquires Cardium Therapeutics In Reverse Acquisition 11
Cardium Therapeutics Completes Private Placement Of $6 Million 12
Equity Offering 13
Cardium Therapeutics Completes Private Placement Of $3.34 Million 13
Cardium Therapeutics Completes Private Placement Of $3.25 Million 14
Cardium Therapeutics Completes Private Placement Of $21.5 Million 15
Cardium Therapeutics Completes $5.31 Million Registered Direct Offering 16
Cardium Therapeutics Completes Private Placement Of $28.98 Million 17
Key Competitors 18
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About Global Markets Direct 20
Contact Us 20
Disclaimer 20

List of Tables
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2009 4
Cardium Therapeutics, Inc., Medical Equipment Deals By Type, 2004 to YTD 2009 5
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2009 6
Cardium Therapeutics, Inc., Deals By Market, 2004 to YTD 2009 7
Cardium Therapeutics, Inc., Medical Equipment, Deals Summary, 2004 to YTD 2009 8
Cardium Therapeutics Acquires Tissue Repair Company 9
Cardium Therapeutics Acquires INNERCOOL therapies 10
Aries Ventures Acquires Cardium Therapeutics In Reverse Acquisition 11
Cardium Therapeutics Completes Private Placement Of $6 Million 12
Cardium Therapeutics Completes Private Placement Of $3.34 Million 13
Cardium Therapeutics Completes Private Placement Of $3.25 Million 14
Cardium Therapeutics Completes Private Placement Of $21.5 Million 15
Cardium Therapeutics Completes $5.31 Million Registered Direct Offering 16
Cardium Therapeutics Completes Private Placement Of $28.98 Million 17
Cardium Therapeutics, Inc., Key Employees 18
Cardium Therapeutics, Inc., Subsidiaries 19

List of Figures 3
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2009 4